ARCHIVES

BMS Settles Charges Of Obstructing Generics

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

Next Bypass Budget: Slim, Trim, Modest

September 15, 1995

Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President.

March 23, 2007

Lineberger Endows Chair To Honor Denman Hammond.

April 13, 2001

Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research

April 15, 2011

New Model For Risk Assessment Includes Alcohol, Exercise, Weight

July 29, 2011

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

November 4, 1988